A typically thought provoking take from Tyler Cowan: I propose that cities and suburbs restrict the sale and usage of marijuana to the same areas we use for garbage disposal and other “zoned out of sight” enterprises. We needn’t throw anyone in jail: If people or businesses violate these strictures, keep hitting them with the … Continue reading “Legalize Pot, But Don’t Normalize It”
Author: Jason Schwartz
The treatment hustle makes Last Week Tonight
This weekend, John Oliver spent nearly 2o minutes describing several of the treatment industry's biggest hustles. https://youtu.be/hWQiXv0sn9Y Is this a sign of the times? Maybe, but it's not new. In Recovery Rising, Bill White describes the business landscape in the 1980s: The trend of private insurance companies paying for the treatment of alcoholism and subsequently … Continue reading The treatment hustle makes Last Week Tonight
Blue Care Network of Michigan tests new opioid treatment with 2 mental health facilities
Why is BCN launching these pilots? "Cost is one factor. We also look at quality of life. Our goal is to help people stay well," said Beecroft, a psychiatrist, geriatrician and substance abuse specialist. "We have looked at return on investment and if you just treat the individual, you get 2-1 investment return. You spend … Continue reading Blue Care Network of Michigan tests new opioid treatment with 2 mental health facilities
Congress is hyperfocused on opioids. Is it focusing enough on addiction?
There's actually an interesting discussion happening in congress right now: A question some lawmakers and journalists often ask is whether Congress is too closely targeting opioids, as the epidemic is a problem of polydrug misuse. Bloomberg’s editorial board warned “lawmakers need to take benzodiazepines seriously, before it’s too late.” (Overdose deaths associated with benzodiazepines are fewer than opioids, … Continue reading Congress is hyperfocused on opioids. Is it focusing enough on addiction?
Effects of MAT on functional outcomes
Recovery from opioid addiction is also more than remission, with remission defined as the sustained cessation or deceleration of opioid and other drug use/problems to a subclinical level—no longer meeting diagnostic criteria for opioid dependence or another substance use disorder. Remission is about the subtraction of pathology; recovery is ultimately about the achievement of global (physical, emotional, relational, … Continue reading Effects of MAT on functional outcomes
Sentences to ponder
"We've been wrong about what our job is in medicine. We think our job is to ensure health and survival. But really it is larger than that. It is to enable well-being. And well-being is about the reasons one wishes to be alive. . . . whatever we can offer, our interventions, and the risks and … Continue reading Sentences to ponder
Overdose crisis? Or, addiction crisis?
British Columbia has long been cited as a model for North American drug policy and harm reduction implementation. BC has established a Death Review Panel in response to the overdose crisis. The panel recently issued a report with 3 recommendations. The first recommendation to regulate recovery homes, which currently require only a simple inspection of … Continue reading Overdose crisis? Or, addiction crisis?
“safely discharged”?
From a press release about newly published research. The title of the press release is Fentanyl overdose survivors require little if any hospital treatment "Our protocol should give emergency physicians and nurses the confidence to allocate the appropriate resources to the patients who truly need them, especially when there is a wave of fentanyl overdoses … Continue reading “safely discharged”?
Exhibit A
Pharma, Pharma, Pharma
MedPage Today reports on a recent NIH, NIDA, HHS press briefing. HHS Secretary Alex Azar, JD, NIH Director Francis Collins, MD, PhD, and Nora Volkow, MD, director of the National Institute on Drug Abuse (NIDA) pitched the president's opioid initiative to reporters during a press briefing on Wednesday afternoon. So, how did they describe their … Continue reading Pharma, Pharma, Pharma
